Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
PAC-1 by Vanquish Oncology for Solid Tumor: Likelihood of Approval
PAC-1 is under clinical development by Vanquish Oncology and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
Data Insights
PAC-1 by Vanquish Oncology for Solid Tumor: Likelihood of Approval
PAC-1 is under clinical development by Vanquish Oncology and currently in Phase I for Solid Tumor. According to GlobalData, Phase...